Campath® Include First-line Treatment for Leading Form of Adult Leukemia
- Details
- Category: Bayer

Teva Receives Positive Feedback on Second AOK Tender in Germany
- Details
- Category: Business

Novo Nordisk receives approval in the EU for use of NovoRapid® in elderly people
- Details
- Category: Novo Nordisk

Long-Term Data Reinforce Safety and Efficacy Profile of Pfizer's New HIV Drug
- Details
- Category: Pfizer

AstraZeneca launches and prices a EUR750 million debut eurobond
- Details
- Category: AstraZeneca

Study Results for Aclidinium Bromide, a Novel Anticholinergic
- Details
- Category: Clinical Trials

Lundbeck and Takeda form Alliance to Develop and Commercialize a Portfolio of Novel Compounds
- Details
- Category: Takeda

More Pharma News ...
- ERS COPD Research Awards 2007 Sponsored by Boehringer Ingelheim
- Invega® receives marketing authorisation in European Union for treatment of schizophrenia
- Novartis completes agreement with Bayer Schering related to Betaseron®
- FDA Accepts NDA Filing for Cleviprex(TM) for the Treatment of Acute Hypertension
- Merck & Co., Inc. Announces Completion of NovaCardia, Inc. Acquisition
- FDA Advisory Committees Recommend Continued US Marketing Authorization for Trasylol
- Sanofi-aventis Announces Settlement of Average Wholesale Price Civil Suits